Detalhe da pesquisa
1.
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
Proc Natl Acad Sci U S A
; 120(3): e2207291120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634138
2.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
J Immunol
; 196(4): 1443-8, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26773145
3.
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy.
Nanomedicine
; 13(1): 191-200, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27720992
4.
γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.
Cell Immunol
; 290(1): 39-51, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24860937
5.
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
J Autoimmun
; 43: 32-43, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514872
6.
Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.
J Immunol
; 187(5): 2405-17, 2011 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21821796
7.
Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4(+) T-cell proliferation and IFN-γ production in response to myelin basic protein and myelin oligodendrocyte glycoprotein.
Eur J Immunol
; 40(10): 2942-56, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20812237
8.
Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis.
Clin Immunol
; 128(3): 382-91, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18599355
9.
The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.
Handb Clin Neurol
; 122: 173-89, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24507518
10.
A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.
ACS Nano
; 8(3): 2148-60, 2014 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24559284
11.
Antibody-independent B cell effector functions in relapsing remitting multiple sclerosis: clues to increased inflammatory and reduced regulatory B cell capacity.
Autoimmunity
; 45(5): 400-14, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22432732
12.
Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.
PLoS One
; 6(2): e17103, 2011 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21359213
13.
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
J Neuroimmunol
; 213(1-2): 123-30, 2009 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19631394